31 Oct
  • By Alicia Clough
  • Cause in

Fourth Annual BLINGO To CureDuchenne Raised $240,000 to Fund Duchenne Muscular Dystrophy Research

Philadelphia, PA (October 31, 2017) – Philadelphia celebrities and more than 250 prominent leaders, community members and guests raised $240,000 to fund Duchenne muscular dystrophy research at the fourth annual BLINGO to CureDuchenne on October 14 at The Westin Philadelphia.  This binged-out evening presented by Cross Properties, benefited CureDuchenne, a national nonprofit that raises awareness […]

READ MORE
26 Oct
  • By Alicia Clough
  • Cause in

CureDuchenne Launches Virtual Durable Medical Equipment Expo for the Duchenne Community

NEWPORT BEACH, Calif., October 26, 2017 – CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, launched the CureDuchenne Cares Virtual Durable Medical Equipment (DME) Expo as a resource for the Duchenne community.  Mobility equipment is important for those with Duchenne as they start to lose ambulation and muscle […]

READ MORE
04 Oct
  • By Alicia Clough
  • Cause in

Fourth Annual BLINGO To CureDuchenne To Honor Dr. Eric Olson

Philadelphia celebrities, prominent leaders and community members to gather for a blinged-out evening benefitting the fight against Duchenne Muscular Dystrophy Philadelphia, PA (October 4, 2017) – CureDuchenne, a national nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, will put the bling in bingo for their fourth annual fundraiser […]

READ MORE
03 Oct
  • By Alicia Clough
  • Cause in

2nd Annual Dealing for Duchenne San Antonio Event to Fund Research to Help Save the Lives of Children with Duchenne Muscular Dystrophy

San Antonio, Texas, October 3, 2017 – Dealing for Duchenne, a charity event to raise funds for research for children afflicted with Duchenne muscular dystrophy, returns to San Antonio on Saturday, October 21.  The event will be held at Pedrotti’s North Wind Ranch in Helotes starting at 6 p.m. and will feature casino games, food, […]

READ MORE
20 Sep
  • By Alicia Clough
  • Cause in

7th Annual Getzlaf Golf Shootout Raises More than $546,000 To Help Find a Cure for Duchenne Muscular Dystrophy

— Anaheim Ducks Captain Ryan Getzlaf and Wife Paige Getzlaf Continue their Support of CureDuchenne –  Newport Beach, CA (Sept. 20, 2017) – The 7th Annual Getzlaf Golf Shootout benefiting CureDuchenne raised more than $546,000 to help find a cure for Duchenne muscular dystrophy. Hosted by Anaheim Ducks Captain Ryan Getzlaf and his wife Paige, […]

READ MORE
15 Jun
  • By Alicia Clough
  • Cause in

RASRx Receives Orphan Drug Designation from FDA

NEWPORT BEACH, Calif., June 15, 2017 – RASRx announced today that the United States Food and Drug Administration (FDA) has granted an Orphan Drug Designation (ODD) for its compound RASRx1902 for the treatment of Duchenne Muscular Dystrophy.  RASRx1902 is an oral therapy that has shown positive effects on muscle function in animal models of Duchenne.  […]

READ MORE
14 Jun
  • By Alicia Clough
  • Cause in

CureDuchenne to Host Webinar with Santhera Pharmaceuticals on SIDEROS Trial

NEWPORT BEACH, Calif., June 14, 2017 –  CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, will host a webinar with Santhera Pharmaceuticals on June 22 at noon ET/9 a.m. PT.   Santhera will provide an update about the ongoing SIDEROS trial, which is a trial of their investigational candidate […]

READ MORE
08 Jun
  • By Alicia Clough
  • Cause in

CureDuchenne Continues to Support Research for Duplication Mutations in Duchenne, and with Dr. Flanigan From Nationwide Children’s Hospital with a Coalition of Families Impacted by the Disease

NEWPORT BEACH, Calif., June 8, 2017: CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, continues to support Dr. Kevin Flanigan from Nationwide Children’s Hospital duplication 2 mutation research to find a treatment for a rare mutation of Duchenne.  CureDuchenne has funded more than $1 million to support this […]

READ MORE
31 May
  • By Alicia Clough
  • Cause in

CD Access to Provide Special Access Program for Duchenne Muscular Dystrophy Patients in Canada

NEWPORT BEACH, Calif., May 31, 2017 –  CD Access is a new nonprofit that provides patients access to drugs and therapies that are currently unavailable through clinical trial or prescription. CD Access’ first program allows Duchenne muscular dystrophy patients in Canada that previously participated in a clinical trial for drisapersen to begin redosing through a […]

READ MORE
15 May
  • By Alicia Clough
  • Cause in

CureDuchenne Support Duchenne Muscular Dystrophy Patients in Nepal

CureDuchenne firmly believes in working together to help any child with Duchenne muscular dystrophy find the support they need. Duchenne is a disorder which knows no cultural, economic, or social boundaries.  This fatal genetic muscle disease affects more than 300,000 children worldwide. Especially affected are muscular dystrophy patients in Nepal, as the region lacks resources […]

READ MORE